Krystal Biotech Inc

NASDAQ:KRYS   3:59:53 PM EDT
60.16
+3.93 (+6.99%)
Earnings Announcements

Krystal Biotech Announces First Quarter 2022 Results

Published: 05/09/2022 22:08 GMT
Krystal Biotech Inc (KRYS) - Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on Operational Progress.
Krystal Biotech Inc - Qtrly Loss per Share $1.99.
Krystal Biotech Inc - Cash, Cash Equivalents, and Investments Totaled $468.0 Million on March 31, 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.01

Next Quarter Revenue Guidance is expected to be $0.2 Million
Next Quarter EPS Guidance is expected to be -$1.05

More details on our Analysts Page.